Today: 7 February 2026
Subscribe
Browse Category

NYSE:NMR News 2 December 2025 - 26 January 2026

Macquarie Group (ASX:MQG) Stock Outlook for December 2025: Qube Bid, Nomura Deal and 2026 Forecast

Macquarie Group (ASX:MQG) Stock Outlook for December 2025: Qube Bid, Nomura Deal and 2026 Forecast

Sydney – 2 December 2025 Macquarie Group Limited (ASX:MQG), Australia’s best‑known investment bank and global infrastructure investor, enters December 2025 in the middle of a major strategic reshaping. The stock is trading around A$193–194 per share, down roughly 10–14% for the year and well below its 2025 highs above A$240, leaving it mid‑range in a 52‑week band of about A$160 to A$243.Intelligent Investor+1 At the same time, Macquarie has: Against this backdrop, analysts still see upside, but they are increasingly split between “Buy” and “Hold” as profits become more cyclical and regulatory risks accumulate. Macquarie share price in early December
2 December 2025
······

Stock Market Today

Mastercard stock price: MA slips as Dow hits 50,000; jobs and CPI data next week

Mastercard stock price: MA slips as Dow hits 50,000; jobs and CPI data next week

7 February 2026
Mastercard shares closed down 0.6% at $548.74 Friday, trailing gains in Visa and American Express. The Dow Jones Industrial Average surged 2.47% to a record 50,115.67. Mastercard disclosed a new cybersecurity partnership in the UAE and raised compensation for two top executives. U.S. jobs and inflation data, delayed by a government shutdown, are due next week.
Costco stock price retakes $1,000 — what traders are watching before Monday

Costco stock price retakes $1,000 — what traders are watching before Monday

7 February 2026
Costco closed Friday up 1.2% at $1,001.16, regaining the $1,000 level as about 2.36 million shares changed hands. January net sales rose 9.3% to $21.33 billion, with comparable sales up 7.1% and online sales surging 34.4%. Wells Fargo raised its price target to $950, maintaining a neutral rating. The next earnings call is set for March 5.
Johnson & Johnson stock price: What to watch after talc-case law firm ouster and new AFib data

Johnson & Johnson stock price: What to watch after talc-case law firm ouster and new AFib data

7 February 2026
Johnson & Johnson shares rose 0.9% to $239.99 Friday after a New Jersey appeals court disqualified Beasley Allen from state talc cases, citing improper coordination with a former J&J attorney. The ruling affects about 3,600 state lawsuits, while a related federal motion is pending. J&J also reported early 12-month pilot data for its investigational AFib device at a cardiology meeting.
Go toTop